| Literature DB >> 31357557 |
Alzeir Machado Rodrigues1,2, Antonio Adailson Sousa Silva3, Cleonilda Claita Carneiro Pinto4, Dayanne Lima Dos Santos5, José Claudio Carneiro de Freitas6, Victor Emanuel Pessoa Martins7, Selene Maia de Morais8.
Abstract
The mosquitoes Aedes aegypti and Aedes albopictus are vectors of arboviruses that cause dengue, zika and chikungunya. Bioactive compounds from plants are environmentally sustainable alternatives to control these vectors and thus the arboviruses transmitted by them. The present study evaluated the larvicidal activity of an acetogenin-rich fraction (ACERF) and its main constituent annonacin obtained from Annona muricata seeds on Ae. aegypti and Ae. albopictus. The larvicidal assays were performed using different concentrations to calculate the LC50 and LC90 values observed 24 h after exposure to the treatment. Annonacin was more active against Ae. aegypti (LC50 2.65 μg·mL-1) in comparison with Ae. albopictus (LC50 8.34 μg·mL-1). In contrast, the acetogenin-rich fraction was more active against Ae. albopictus (LC50 3.41 μg·mL-1) than Ae. aegypti (LC50 12.41 μg·mL-1). ACERF and annonacin treated larvae of Ae. aegypti and Ae. albopictus showed significant differences in the inhibition of their metabolic enzymes when compared to untreated larvae. The results demonstrate the relevant larvicidal action of the acetogenin-rich fraction and annonacin showing the potential to develop new products for the control of Ae. aegypti and Ae. albopictus.Entities:
Keywords: Aedes; annonacin; botanicals; larvicidal
Year: 2019 PMID: 31357557 PMCID: PMC6789477 DOI: 10.3390/ph12030112
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Figure 1Chromatogram of the ACERF.
Figure 2UV curve of the main acetogenin isolated from the acetogenin-rich extract of A. muricata.
Figure 3Representation of chemical structure of annonacin.
Lethal concentration of the fraction rich in acetogenins of A. muricata against fourth instar larvae of Ae. aegypti and Ae. Albopictus.
| Mosquito Strains | LC50 (CL at 95%) | LC90 (CL at 95%) |
|---|---|---|
|
| 12.41 (9.85–14.86) | 30.21 (26.17–36.52) |
|
| 3.41 (2.83–4.00) | 6.17 (5.37–7.43) |
| 26.75 (21.36–34.00) | 54.46 (44.78–71.01) |
Control: no mortality. As the level of significance is greater than 0.05, no heterogeneity factor was used in the calculation of confidence limits. LC50: concentration that kills 50% of the exposed larvae (in μg·mL−1) with confidence limit at 95%. LC90: concentration that kills 90% of the exposed larvae (in μg·mL−1) with confidence limit at 95%.
Lethal concentration of annonacin from A. muricata against fourth instar larvae of Aedes spp.
| Mosquito Strains | LC50 (CL at 95%) | LC90 (CL at 95%) |
|---|---|---|
| 2.65 (1.87–3.64) | 4.83 (3.80–7.35) | |
|
| 8.34 (7.10–10.26) | 16.30 (13.56–21.13) |
Control: no mortality. As the level of significance is greater than 0.05, no heterogeneity factor was used in the calculation of confidence limits. LC50: concentration that kills 50% of the exposed larvae (in μg·mL−1) with confidence limit at 95%. LC90: concentration that kills 90% of the exposed larvae (in μg·mL−1) with confidence limit at 95%.
Figure 4Enzymatic changes of total proteins (A), alkaline phosphatase (B), acid phosphatase (C), proteases (D), esterases (E) and amylases (F) between larvae treated and untreated with the ACERF of A. muricata. Different lowercase letters on the bar denote significant difference (p < 0.05). Bar represent the standard deviations (n = 2). Values estimated by one-way ANOVA followed by Tukey’s test. Control: untreated larvae.
Figure 5Enzymatic changes of total proteins (A), alkaline phosphatase (B), acid phosphatase (C), proteases (D), esterases (E) and amylases (F) between larvae treated and untreated with the annonacin of A. muricata. Different lowercase letters on the bar denote significant difference (p < 0.05). Bar represent the standard deviations (n = 2). Values estimated by one-way ANOVA followed by Tukey’s test. Control: untreated larvae.